Atom | NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Due Dates (Anticipated): September 2026 (estimated full application deadline)

Funding Amounts: Not specified in the forecast; typical SBIR awards vary by phase and institute.

Summary: Supports innovative health-related research and development by eligible U.S. small businesses through the SBIR Phase I, Phase II, and Fast-Track mechanisms.

Key Information: Only U.S. small businesses (SBCs) as defined by SBA are eligible; this is a forecasted opportunity.

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Sign in to see full grant listing